Artificial Intelligence in Pharmacy: A Boon for Drug Delivery & Drug Discovery
Artificial Intelligence (AI) is increasingly recognized as a game-changer in the pharmaceutical industry, especially in the fields of drug discovery and drug delivery. The integration of Artificial Intelligence (AI) into pharmacy practices represents a transformative advancement in drug delivery systems. Recent pharmaceutical research shows that significantly evolved artificial intelligence (AI) and machine learning Techniques are promising to facilitate the drug delivery system development. The intersection of artificial intelligence (AI) and pharmacy has ushered in a new era of drug delivery, marked by unprecedented precision, efficiency, and personalization. AI, with its ability to process vast amounts of data, identify patterns, and make intelligent decisions, is revolutionizing various aspects of drug development, manufacturing, and distribution. This paper explores the profound impact AI technologies are having on the optimization of pharmaceutical delivery mechanisms. By examining recent innovations and case studies, this presentation elucidates how AI is revolutionizing drug delivery, offering a substantial boon to pharmaceutical practice and patient care. AI can process big data, reveal potential correlations, provide accurate predictions, and navigate in a high-dimensional space, offering great potential to change the drug delivery research paradigm. Data-driven approaches can be applied to all aspects of the pharmaceutical field, across preformulation studies, formulation screening, and precision medicine in the clinic. Personalized medicine approaches can be facilitated through AI algorithms that analyze real-world patient data, leading to more effective treatment outcomes and improved patient adherence. Artificial Intelligence (AI) is revolutionizing the field of drug discovery by enhancing the efficiency, accuracy, and speed of identifying potential drug candidates. AI technologies, such as machine learning, deep learning, and natural language processing, are being increasingly integrated into various stages of drug discovery, including target identification, compound screening, lead optimization, and clinical trial design. This review explores the transformative potential of AI, focusing on how it is revolutionizing both the discovery of new drugs and the optimization of drug delivery systems.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-12-04
- DOI
- https://doi.org/10.5281/zenodo.14272916
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00